Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2361 - 2368 of 11621 results
Federal Jury Concludes Cryptocurrency Products NOT Securities
November 4, 2021| Blog| Viewpoint
Mintz Adds ITC Pro From Adduci Mastriani
November 3, 2021| News
What’s New in 5G - November 2021
November 3, 2021| Blog| Viewpoint
NYSDOL Issues Guidance Regarding Employee Use of Cannabis
November 3, 2021| Blog| Viewpoint
Importance of a Firm Brand: Passle Podcast CMO Series
November 3, 2021| Podcast| Viewpoint
Briefings on HIPAA: Inside the 21st Century ONC Cures Act
November 1, 2021| News
Life Sciences CEO Interview: Joe Payne, President and CEO of Arcturus Therapeutics
November 1, 2021| Blog| Viewpoint
Mintz Life Sciences Deal Activity (July– September 2021)
November 1, 2021| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.